A novel biomarker of Alzheimer’s disease progression: LTP-like cortical plasticity

Francesco Di Lorenzo, MD from the Santa Lucia Foundation IRCCS, Rome, Italy gives an overview of a study investigating LTP-like cortical plasticity as biomarker for disease progression in Alzheimer’s disease patients. Dr Di Lorenzo explains that they used transcranial magnetic stimulation to study cortical plasticity mechanisms, especially long term potentiation (LTP), in order establish the predictive value of LTP-like cortical plasticity as a prognostic biomarker of disease progression.
Recorded at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands.

Share this video